AC Immune shows first brain images of TDP-43 pathology in phase 1 trial

March 19, 2026 7:00 AM

AC Immune SA (NASDAQ: ACIU) presented initial data from its Phase 1 trial of PET tracer ACI-19626, showing the first ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found